Vividion Therapeutics logo

Vividion Therapeutics

Vividion Therapeutics is a proprietary Screening founded in 2017.

3

Funding Rounds

$267.0m

Money raised

Overview

Vividion Therapeutics is a proprietary Screening founded in 2017.

Funding

Funding series

Funding Series Analysis

The company Vividion Therapeutics has raised a total of $132m in funding over 3 rounds.

Key Insights:

  • Vividion Therapeutics Series B round Funding Round 2019: $82m
  • Vividion Therapeutics Series A round, February 2017: $50m
  • Vividion Therapeutics, Inc. funding round, March 2021: $135m
Vividion Therapeutics logo
Vividion Therapeutics Series B round Funding Round 2019 $82m
Vividion Therapeutics logo
Vividion Therapeutics Series A round, February 2017 $50m
Vividion Therapeutics logo
Vividion Therapeutics, Inc. funding round, March 2021 $135m

Industries

Vividion Therapeutics is active in the following industries:
  • Biomedical engineering
  • Biopharmaceutical
  • Proteomics
  • Engineering
  • Technology
  • Biology
  • Biotechnology